Lyra Therapeutics Cash Flow Statement (2021-2025) | LYRA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -7.80M-11.04M-11.05M-13.62M-11.91M-14.37M-14.77M-14.22M-16.25M-15.62M-15.65M-15.16M-22.45M-48.13M-11.87M-10.98M-8.55M-7.44M-5.98M-6.95M
Depreciation and Depletion (Quarter) 0.07M0.30M0.40M0.28M0.28M0.30M0.30M0.26M0.28M-0.02M-0.07M0.11M0.10M0.20M0.10M0.17M0.10M0.20M0.10M0.06M
Share-based Compensation (Quarter) 0.60M0.66M0.73M0.78M0.84M1.11M1.74M1.76M1.61M1.35M1.44M1.48M2.16M1.12M1.49M1.94M0.82M0.91M0.03M0.56M
Gains from Sales and Divestitures (Quarter) 0.00M0.00M0.01M0.01M0.01M0.01M0.13M0.03M0.03M0.09M0.37M0.02M0.03M0.04M
Gains from Investment Securities (Quarter) 0.00M0.07M1.85M0.04M0.05M1.42M1.98M0.43M0.63M13.67M7.05M-13.57M2.97M0.07M0.06M
Asset Writedowns and Impairment (Quarter) 1.59M0.01M1.88M1.76M
Cash from Restructuring (Quarter) 1.73M-0.51M-0.31M-0.55M-0.43M0.21M
Non-cash Items (Quarter) 0.67M2.98M0.81M0.92M0.77M3.54M1.92M0.38M0.06M3.09M2.65M6.33M12.87M1.40M1.30M0.05M
Cash from Operations (Quarter) -7.59M3.38M-10.31M-11.30M-11.90M-8.47M-10.85M-12.16M-15.85M-14.28M-14.11M-19.06M-22.45M-19.98M-16.22M-11.35M-8.84M-6.59M-7.36M-6.07M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.73M0.63M1.06M1.09M0.93M0.68M0.40M0.27M
Depreciation & Amortization (CF) (Quarter) 0.07M0.30M0.40M0.28M0.28M0.30M0.30M0.26M0.28M-0.02M-0.07M0.11M0.10M0.20M0.10M0.17M0.10M0.20M0.10M0.06M
Change in Working Capital
Change in Account Payables (Quarter) 0.45M0.29M0.42M1.18M-0.66M-0.98M1.47M-2.24M3.29M-0.11M0.80M-3.54M-0.56M2.38M-2.59M-1.11M-0.45M-0.04M-0.12M0.10M
Change in Accured Expenses (Quarter) -0.98M0.96M0.99M0.28M-0.09M1.29M1.61M1.96M-2.32M-0.61M2.30M2.12M0.83M-3.33M-2.90M-0.57M-0.34M-0.20M-0.94M-0.33M
Investing Activities
Capital Expenditures (Quarter) 1.16M0.62M-0.74M2.34M0.09M-0.09M0.13M0.03M0.04M0.07M-0.11M0.61M0.35M-0.29M2.33M-0.06M0.10M
Change in Acquisitions & Divestments (Quarter) 9.80M25.00M28.00M48.09M30.53M50.99M21.00M28.07M
Cash from Investing Activities (Quarter) -1.16M-0.62M-0.52M-1.08M-0.09M-0.01M-0.03M-64.87M5.32M-0.56M-14.98M-2.36M7.86M36.18M8.14M28.13M-0.10M
Financing Activities
Other financing activities (Quarter) 0.10M0.00M0.00M4.01M0.24M0.42M0.32M0.17M0.10M0.02M0.37M
Change in Capital Stock
Shares Issued (Quarter) 0.26M0.33M0.01M0.01M0.00M0.10M0.00M0.00M
Misc.
Cash from Financing Activities (Quarter) 0.26M0.18M-0.08M-0.00M0.01M96.49M-0.24M0.00M47.19M-0.42M18.92M8.64M-0.09M-0.02M-0.00M-0.37M
Change in Cash (Quarter) -8.49M2.94M-10.91M-12.38M-11.99M88.00M-11.11M-77.03M-10.53M32.34M-29.51M-2.50M-5.95M16.11M-8.11M16.78M-8.84M-1.95M-7.73M-6.16M
Free Cash Flow (Quarter) -8.75M2.76M-9.58M-13.63M-12.00M-8.38M-10.98M-12.19M-15.89M-14.35M-14.01M-19.67M-22.80M-19.70M-18.55M-11.29M-8.84M-6.59M-7.36M-6.16M
Net Cash Flow (Quarter) -8.49M2.94M-10.91M-12.38M-11.99M88.00M-11.11M-77.03M-10.53M32.34M-29.51M-2.50M-5.95M16.11M-8.11M16.78M-8.84M-6.59M-7.73M-6.16M